However, gender, primary tumour location, and the XRCC1-rs25487, ERCC1-rs11615, ERCC2-rs238406, and ERCC2-rs13181 polymorphisms were not statistically associated with 5-year OS (p’s > 0.05). This evidence concerns the gene ERCC1 and neoplasm.